港股異動 | 康龍化成(3759.HK)大漲近11% 2020年擁有人應占利潤大增114.3%
格隆匯3月30日丨康龍化成(3759.HK)大幅拉昇至10.85%,報150.2港元,暫成交1.46億港元,總市值1193億港元。康龍化成A股亦升超7%。康龍化成28日發佈2020年業績,公司實現收益51.3億元人民幣(單位下同),同比增長36.6%;擁有人應占利潤11.72億元,同比增長114.3%;基本每股收益1.4825元。建議派發末期息每股0.3元,按年增加1倍。此外,公司日前獲摩根士丹利增持40.9505萬股,涉資約5049.02萬港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.